Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Archives
    • Special Issue Archive
    • Ahead of Print
    • Abstracts In Press
    • Subject Collections
    • Editors' Blog
    • Email Alerts
  • Info For
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • About
    • The JABFM
    • Editorial Board
    • Indexing
  • Classifieds
  • More
    • Email Alerts
    • Feedback
    • ABFM News
    • Folders
    • Help
  • JABFM On Twitter
  • JABFM On YouTube
  • JABFM On Facebook
OtherEvidence-Based Clinical Medicine

Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis

Miguel G. Madariaga, Ziba Jalali and Susan Swindells
The Journal of the American Board of Family Medicine November 2007, 20 (6) 540-547; DOI: https://doi.org/10.3122/jabfm.2007.06.070109
Miguel G. Madariaga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziba Jalali
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan Swindells
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    Figure 1.

    Procedure and result interpretation of ELISA T-cell–based gamma release essay. ESAT-6 and CFP-10 refer to specific antigens coded by the esat-6 and lhp genes of Mycobacterium tuberculosis. For indeterminate results, the test may be repeated if there is evidence of potential technical errors, such as storage at incorrect temperature, pipetting errors, etc.

Tables

  • Figures
    • View popup
    Table 1.

    Comparison of QuantiFERON-TB Gold and Tuberculin Skin Testing

    QuantiFERON-TB GoldTST
    How is the test performed?Laboratory measurement of interferon-gamma in whole bloodIntradermal injection of purified protein derivative and measurement of resulting induration
    What does the test measure?In vitro release of interferon gamma after exposure to specific M. tuberculosis antigensIn vivo type intradermal hypersensitivity after injection of a mixture of mycobacterial antigens (not only M. tuberculosis)
    Ability to detect tuberculous infectionYesYes
    Ability to distinguish latent and active tuberculosisNoNo
    False positive resultsYes, but less frequently than with the TST. False-positive results may occur with exposure to selected nontubercular mycobacteria, but not after BCG vaccination.Yes. False-positive results may occur after exposure to nontubercular mycobacteria or after BCG vaccination.
    False negative resultsPossible among immunosuppressed individualsPossible among immunosuppressed individuals
    Effect of BCG vaccinationNoneMay give a false-positive result after BCG vaccination
    Need for patient to return for second visitNoYes, for reading of the skin reaction
    Required infrastructureYes. Special equipment required in the laboratoryNo special infrastructure required. Easy to perform even in unsophisticated facilities
    Subjectivity in reporting resultsNoYes, it may vary depending on training of individual
    CostMore expensiveLess expensive
    Time to obtain resultAt least 24 hours, but longer if run in batchesAt least 48 hours
    Boosting an anamnestic response with successive testsNoYes
    • TST, tuberculin skin test; BCG, Bacillus Calmette-Guérin.

    • View popup
    Table 2.

    Sensitivity and Specificity of QuantiFERON-TB Gold and Agreement Between QuantiFERON-TB Gold and Tuberculin Skin Testing

    Agreement with TST79–94
    Specificity in latent tuberculosis89–100
    Sensitivity in latent tuberculosis90
    Specificity in active tuberculosis97–100
    Sensitivity in active tuberculosis72–89
    • All values shown as percentages. TST, tuberculin skin test.

    • View popup
    Table 3.

    Take-Home Points

    IGRA can be used in any evaluation for tuberculosis infection (active or latent).
    IGRA are more specific than TSTs, which may be positive because of previous BCG vaccination or exposure to non-tuberculosis Mycobacterium.
    A positive IGRA indicates tuberculosis infection but does not differentiate between active or latent infection.
    A negative IGRA excludes tuberculosis in immunocompetent patients.
    Immunosuppressed patients are more likely to have indeterminate results.
    IGRA does not require a second visit to read the results.
    IGRA is more costly and requires processing within 12 hours of collection.
    • IGRA, interferon gamma release assays; TST, tuberculin skin test; BCG, Bacillus Calmette-Guérin.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 20 (6)
The Journal of the American Board of Family Medicine
Vol. 20, Issue 6
November-December 2007
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis
Miguel G. Madariaga, Ziba Jalali, Susan Swindells
The Journal of the American Board of Family Medicine Nov 2007, 20 (6) 540-547; DOI: 10.3122/jabfm.2007.06.070109

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Utility of Interferon Gamma Assay in the Diagnosis of Tuberculosis
Miguel G. Madariaga, Ziba Jalali, Susan Swindells
The Journal of the American Board of Family Medicine Nov 2007, 20 (6) 540-547; DOI: 10.3122/jabfm.2007.06.070109
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • ELISA T-Cell–based INF-γ Release Assay
    • Potential Drawbacks
    • Unanswered Questions and Further Directions
    • Conclusions
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Gamma Interferon Assays Used in the Diagnosis of Tuberculosis
  • Advances in Diagnosis and Treatment of Latent Tuberculosis Infection
  • Google Scholar

More in this TOC Section

  • Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians
  • Interpreting COVID-19 Test Results in Clinical Settings: It Depends!
  • Current Indications for Tonsillectomy and Adenoidectomy
Show more Evidence-Based Clinical Medicine

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us

© 2022 American Board of Family Medicine

Powered by HighWire